Africa Cancer Leaders Institute

非洲癌症领袖研究所

• 批准号: 10754192
• 负责人: OLUFUNMILAYO F. OLOPADE
• 金额: $ 3万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-20 至 2026-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10754192
• 关键词: Advocacy; Africa; African; Area; Award; Clinical; Clinical Trials; Collaborations; Competence; Country; Development; Early identification; Education; Electronic Medical Records and Genomics Network; Emerging Technologies; Ethics; Evaluation; Faculty; Fostering; Foundations; Friends; Funding; Future; Generations; Genetic; Genomics; Goals; Grant; Income; Individual; Knowledge; Leadership; Learning; Location; Malignant Neoplasms; Mentors; Mentorship; Minority; Participant; Pathology; Persons; Policies; Portuguese; Productivity; Publications; Publishing; Records; Regional Cancer; Reporting; Research; Research Personnel; Research Training; Role; Senegal; Training; Translating; Travel; United States National Institutes of Health; Woman; aluminum sulfate; anticancer research; brain circulation; cancer therapy; career; career development; clinical development; cohort; design; experience; forging; improved; innovation; leadership development; lectures; meetings; member; novel strategies; outreach; peer; peer coaching; programs; recruit; research and development; symposium

PROJECT SUMMARY The proposed renewal application for African Cancer Leaders Institute (ACLI) is a “meeting within a meeting” designed to coincide with conferences organized by the African Organization for Research Training In Cancer (AORTIC) conference, beginning with the forthcoming, “Cancer in Africa: Implementation, Workforce, and Opportunities” in Dakar, Senegal, November 3-8, 2023.The ACLI will identify early career researchers, especially women and individuals underrepresented in global cancer research who are capable of leading interdisciplinary teams to improve cancer treatment in Africa. The long-term goal of the ACLI is to provide an intellectually stimulating platform to propel emerging global cancer leaders from Africa and the US to receive support for innovative cancer research in Africa, and to stimulate an African network for emerging leaders in cancer research. The ACLI platform will have annual goals and objectives set by the Education and Research Sub- Committees of AORTIC in collaboration with the ACLI program Organizers. The ACLI will widely solicit competitive applications from aspiring leaders in Africa and the US. During the past funding cycle, three cohorts of ACLI participants (60 total) were recruited and participated in AORTIC Conferences in Durban in 2017, Maputo in 2019 and Senegal in 2022 during a mini-retreat for ACLI members and AORTIC Council Members at the 1st African Regional Cancer Conference (ARCC) planned and hosted by AORTIC Leadership in West Africa. Awardees from all cohorts were invited to participate and 21 attended in person. It was gratifying to note enthusiastic participation by investigators from West Africa, especially those from French and Portuguese speaking countries. Most of the ARCC lectures were given by ACLI participants and researchers working in Africa who reported having received 6 NIH and 5 foundation grants. ACLI participants were unanimous in endorsing the need for a regional conference every other year that will provide greater capacity building opportunities and more succinct leadership programing for ACLI. For this renewal application, 10 Emerging Leaders will be fully-funded for travel to attend the AORTIC conference and participate in ACLI activities. Five emerging Leaders from high-income countries with meritorious abstracts and application will be selected for Merit travel award in order to continue to forge professional relationships and foster peer mentorship. ACLI participants will mostly network in groups of 6-8 with conversations on specific topics facilitated by Faculty and attend scientific sessions. For peer mentoring, sessions will be arranged for ACLI participants to discuss and evaluate concepts presented at the conference to enhance learning and career development experience. Each new ACLI participant will be asked to prepare a brief 15-minute overview of career accomplishments and plans for their career development activities. We will continue to track a number of metrics including conference evaluations, career landmarks, publication records and the number of ACLI members who compete successfully for Africa focused NIH/NCI grants e.g K43, K07, K23, R21 etc.

项目摘要 非洲癌症领导人研究所（ACLI）的拟议延期申请是一次“会议中的会议” 旨在配合非洲癌症研究培训组织举办的会议， （AORTIC）会议，首先是即将举行的“非洲癌症：执行、劳动力和 机会”在达喀尔，塞内加尔，2023年11月3日至8日。ACLI将确定早期职业研究人员，特别是 在全球癌症研究中代表性不足的妇女和个人， 改善非洲癌症治疗的团队。ACLI的长期目标是提供一个智力上的 激励平台，推动来自非洲和美国的新兴全球癌症领导人获得支持， 在非洲开展创新性癌症研究，并促进建立一个非洲癌症领域新兴领导人网络 research. ACLI平台将有教育和研究小组设定的年度目标和目的， AORTIC委员会与ACLI计划组织者合作。ACLI将广泛征求 来自非洲和美国有抱负的领导者的竞争性申请。在上一个供资周期， 2017年，招募了60名ACLI参与者并参加了在马普托德班举行的AORTIC会议 在2019年和2022年塞内加尔举行的第一届ACLI成员和AORTIC理事会成员小型务虚会上， 非洲区域癌症会议（ARCC）由AORTIC领导人在西非规划和主办。 所有组别的获奖者都被邀请参加，21人亲自参加。令人欣慰的是 来自西非的调查人员，特别是来自法国和葡萄牙的调查人员的热情参与 说的国家。大多数ARCC讲座都是由ACLI的参与者和研究人员在 非洲国家报告获得了6项国家卫生研究所赠款和5项基金会赠款。ACLI与会者一致认为， 赞同有必要每两年举行一次区域会议，以加强能力建设 机会和更简洁的领导力ACLI计划。对于此更新申请，10新兴 领导人将全额资助旅行出席AORTIC会议和参加ACLI活动。 来自高收入国家的五位具有杰出摘要和应用程序的新兴领导人将被 被选为优秀旅行奖，以继续建立专业关系和培养同行 导师制ACLI的参与者将主要以6-8人为一组，就特定主题进行对话 由教师协助，并参加科学会议。在同侪辅导方面，将为ACLI安排课程 参加者讨论及评估会议上提出的概念，以促进学习和职业发展 发展经验。每个新的ACLI参与者将被要求准备一个简短的15分钟的概述， 职业成就和职业发展活动计划。我们将继续跟踪一些 指标包括会议评估，职业里程碑，出版记录和ACLI的数量 成功竞争以非洲为重点的NIH/NCI资助的成员，例如K43，K 07，K23，R21等。